| News

AusVaxSafety commences routine monitoring of 2022 seasonal influenza vaccines

With 2022 seasonal influenza vaccines now available across Australia, AusVaxSafety has commenced active surveillance to monitor the safety of the vaccines in near-real time.

AusVaxSafety sends out a short online survey via SMS or email to individuals (or their parent/carer) who receive their influenza vaccine at a participating AusVaxSafety site, allowing participants to report any side effects they may have experienced after vaccination.

De-identified data from completed surveys are analysed and monitored by epidemiologists and vaccine experts to ensure that vaccines are performing as safely as expected in real-world conditions.

These data provide a profile of what to expect in the days following influenza vaccination and are an excellent resource for immunisation providers when counselling patients on influenza vaccination.

AusVaxSafety has monitored the safety of influenza vaccines administered to Australians of all ages since 2017. Since then, more than 750,000 individuals (or their parent/carer) have provided details about any side effects experienced after influenza vaccination.

AusVaxSafety data for the 2022 influenza vaccines will be available on the AusVaxSafety website from Wednesday 20 April 2022 and updated weekly.

View the influenza vaccine safety data page here